These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1229 related articles for article (PubMed ID: 25632912)

  • 1. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
    Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
    Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
    Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry.
    Shi Y; Tan N; Zhang N; Xiong L; Peng S; Lin J; Chen M; Xiao Y
    Neurogastroenterol Motil; 2016 May; 28(5):674-9. PubMed ID: 26768192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impedance-high resolution manometry analysis of patients with nonerosive reflux disease.
    Ribolsi M; Holloway RH; Emerenziani S; Balestrieri P; Cicala M
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):52-7. PubMed ID: 23891920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal hypermotility: cause or effect?
    Crespin OM; Tatum RP; Yates RB; Sahin M; Coskun K; Martin AV; Wright A; Oelschlager BK; Pellegrini CA
    Dis Esophagus; 2016 Jul; 29(5):497-502. PubMed ID: 25893778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personalized diagnosis of patients with gastroesophageal reflux disease using 24-hour pH-impedance testing and high-resolution esophageal manometry].
    Maev IV; Yurenev GL; Barkalova EV; Ovsepian MA; Andreev DN; Shaburov RI
    Ter Arkh; 2024 Sep; 96(8):757-763. PubMed ID: 39404720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy.
    Savarino E; Zentilin P; Tutuian R; Pohl D; Casa DD; Frazzoni M; Cestari R; Savarino V
    Am J Gastroenterol; 2008 Nov; 103(11):2685-93. PubMed ID: 18775017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of gastroesophageal reflux in relation to symptom onset in patients with proton pump inhibitor-refractory nonerosive reflux disease accompanied by an underlying esophageal motor disorder.
    Izawa S; Funaki Y; Iida A; Tokudome K; Tamura Y; Ogasawara N; Sasaki M; Kasugai K
    Digestion; 2014; 89(1):61-7. PubMed ID: 24458115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective use of esophageal manometry and 24-Hour pH monitoring before laparoscopic fundoplication.
    Frantzides CT; Carlson MA; Madan AK; Stewart ET; Smith C
    J Am Coll Surg; 2003 Sep; 197(3):358-63; discussion 363-4. PubMed ID: 12946787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal motor dysfunction plays a key role in GERD with globus sensation--analysis of factors promoting resistance to PPI therapy.
    Tsutsui H; Manabe N; Uno M; Imamura H; Kamada T; Kusunoki H; Shiotani A; Hata J; Harada T; Haruma K
    Scand J Gastroenterol; 2012 Sep; 47(8-9):893-9. PubMed ID: 22594305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Gastroesophageal Reflux by Combined Multichannel Intraluminal Impedance and pH Monitoring and Esophageal Motility Patterns in Children with Esophageal Atresia.
    Tong S; Mallitt KA; Krishnan U
    Eur J Pediatr Surg; 2016 Aug; 26(4):322-31. PubMed ID: 26445355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of Double-Dose Proton Pump Inhibitor-Resistant Non-Erosive Reflux Disease, and Mechanism of Reflux Symptoms and Gastric Acid Secretion-Suppressive Effect in the Presence or Absence of Helicobacter pylori Infection.
    Kawami N; Takenouchi N; Umezawa M; Hoshino S; Hanada Y; Hoshikawa Y; Sano H; Hoshihara Y; Nomura T; Uchida E; Iwakiri K
    Digestion; 2017; 95(2):140-145. PubMed ID: 28161707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology and Treatment of PPI-resistant NERD].
    Kawami N; Iwakiri K; Sakamoto C
    Nihon Rinsho; 2015 Jul; 73(7):1197-201. PubMed ID: 26165080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
    Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE
    Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure.
    de Bortoli N; Martinucci I; Savarino E; Franchi R; Bertani L; Russo S; Ceccarelli L; Costa F; Bellini M; Blandizzi C; Savarino V; Marchi S
    Dis Esophagus; 2016 Jan; 29(1):3-9. PubMed ID: 25212408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Esophageal motility characteristics of refractory heartburn: a study based on high resolution manometry and 24 hour pH-impedance monitoring].
    Wang K; Duan L; Xia Z; Xu Z; Ge Y
    Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(34):2650-5. PubMed ID: 25511590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.